Xeroflam 3 Tablet is a combination pharmaceutical formulation containing Bromelain 90 mg, Trypsin 48 mg, and Rutoside 100 mg, designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits potent anti-inflammatory and analgesic properties by modulating inflammatory mediators and reducing edema. Trypsin, another proteolytic enzyme, facilitates the breakdown of proteins in inflamed tissues, promoting faster resolution of inflammation and enhancing tissue repair. Rutoside, a bioflavonoid, acts as a vascular protector by strengthening capillary walls, reducing capillary permeability, and exhibiting antioxidant effects, thereby minimizing microvascular bleeding and edema. The synergistic action of these components makes Xeroflam 3 effective in managing acute and chronic inflammatory conditions such as postoperative swelling, musculoskeletal injuries, and inflammatory edema. It is commonly prescribed as an adjunct therapy in trauma, sports injuries, and post-surgical recovery to accelerate healing and reduce pain and inflammation. Xeroflam 3 should be administered under medical supervision, with dosage adjusted according to the severity of the condition and patient response. Contraindications include hypersensitivity to any component, active bleeding disorders, and caution in patients with gastrointestinal ulcers or coagulopathies.